| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/06/2010 | US20100111932 Antibodies against ramp3 |
| 05/06/2010 | US20100111930 Methods and Compositions for Detecting Receptor Ligand Mimetics |
| 05/06/2010 | US20100111925 Compositions of Engineered Human Arginases and Methods for Treating Cancer |
| 05/06/2010 | US20100111905 Methods for improved engraftment following stem cell transplantation |
| 05/06/2010 | US20100111901 Triazole inhibitors of aromatase |
| 05/06/2010 | US20100111898 Conjoint therapy for treating fibrotic diseases |
| 05/06/2010 | US20100111894 Metap-2 inhibitor polymersomes for therapeutic administration |
| 05/06/2010 | US20100111879 Saccharide foamable compositions |
| 05/06/2010 | US20100111874 Method of cancer detection and treatment |
| 05/06/2010 | US20100111873 Treating cancer with viral nucleic acid |
| 05/06/2010 | US20100111867 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging |
| 05/06/2010 | US20100111866 Receptor and Antigen Targeted Prodrug |
| 05/06/2010 | US20100111864 18f-labelled folates |
| 05/06/2010 | US20100111863 18f-labelled folates |
| 05/06/2010 | US20100111860 Radioactive material containing chitosan for inhibiting cancer and preparation method thereof |
| 05/06/2010 | US20100111858 Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands |
| 05/06/2010 | US20100111854 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111852 Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same |
| 05/06/2010 | US20100111850 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | US20100111839 Selective inhibitors of translesion dna replication |
| 05/06/2010 | US20100111835 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | CA2779436A1 Light targeting molecules and uses thereof |
| 05/06/2010 | CA2742497A1 Compositions of engineered human arginases and methods for treating cancer |
| 05/06/2010 | CA2742049A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
| 05/06/2010 | CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same |
| 05/06/2010 | CA2741831A1 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 05/06/2010 | CA2741798A1 Anti-muc1 antibody |
| 05/06/2010 | CA2741783A1 Compounds having tafia inhibitory activity |
| 05/06/2010 | CA2741606A1 Novel salts of sunitinib |
| 05/06/2010 | CA2740558A1 Poly-heteroaryl derivatives for the treatment of cancer |
| 05/06/2010 | CA2740058A1 An antidiabetic agent |
| 05/06/2010 | CA2738909A1 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 05/06/2010 | CA2736361A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor |
| 05/05/2010 | EP2182073A1 Ubiquitin specific proteases responsible for MCL-1 stability and uses thereof |
| 05/05/2010 | EP2182063A2 Modulation of EIF4E expression |
| 05/05/2010 | EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide |
| 05/05/2010 | EP2181991A1 Novel salts of sunitinib |
| 05/05/2010 | EP2181990A1 Piperidine derivative |
| 05/05/2010 | EP2181987A1 Heterocyclic compound and use thereof |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181713A1 Pharmaceutical compositions for prevention or treatment of Lewis Y antigen related diseases and kits for detecting Lewis Y antigen |
| 05/05/2010 | EP2181111A1 Thiadiazinone derivatives |
| 05/05/2010 | EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 05/05/2010 | EP2181104A1 Zearalenone macrolide derivatives and uses of the same |
| 05/05/2010 | EP2181099A2 Crystalline forms of erlotinib hcl and formulations thereof |
| 05/05/2010 | EP2181092A1 1,3-dihydroisoindole derivatives |
| 05/05/2010 | EP2180896A2 Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs |
| 05/05/2010 | EP2180893A2 Pharmaceutical compositions and methods for the treatment of cancer |
| 05/05/2010 | EP2180890A1 Methods of inhibiting or suppressing cellular proliferation |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1702982B1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
| 05/05/2010 | EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 05/05/2010 | EP1390026B1 Treatment of hpv caused diseases |
| 05/05/2010 | EP1328504B1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | EP1167366B1 Amine derivatives |
| 05/05/2010 | EP1166788B1 Remedies for joint diseases |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 05/05/2010 | CN1985937B Medicine for treating hepatic duct tumor and its preparing method |
| 05/05/2010 | CN1982327B Phytosterin compound and its use |
| 05/05/2010 | CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/05/2010 | CN1958794B Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application |
| 05/05/2010 | CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 05/05/2010 | CN1923282B Anti-cancer slow release injection comprising hormone drug |
| 05/05/2010 | CN1923281B Anti-cancer slow release injection comprising plant alkaloid |
| 05/05/2010 | CN1921875B Beverage and medicine having bamboo extractive as main component |
| 05/05/2010 | CN1919214B Monascus soft capsule and its preparation method |
| 05/05/2010 | CN1807413B Carbazole sulfonamide derivative and its preparation method |
| 05/05/2010 | CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 05/05/2010 | CN1752104B Monoclonal antibody of synapse protein gamma and its application |
| 05/05/2010 | CN1679912B Extraction of liuwei Dihuang polysaccharide, products and use thereof |
| 05/05/2010 | CN1657100B Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 05/05/2010 | CN1548537B Vaccine preparing process and antitumor vaccine |
| 05/05/2010 | CN1525859B Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 05/05/2010 | CN1511036B Combination comprising signal transduction inhibitor and epothilone derivative |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN101701220A Breast cancer related gene C10RF64 and application thereof |
| 05/05/2010 | CN101701217A SiRNA restraining gene expression of transcription factor Spl and application thereof |
| 05/05/2010 | CN101701107A Preparation method of mock-strawberry fruit haematochrome |
| 05/05/2010 | CN101701024A Ruthenium complex, preparation method thereof and application thereof |
| 05/05/2010 | CN101701018A 2-(4-aminoquinazoline) benzo [d] thiazole derivative and application thereof |
| 05/05/2010 | CN101700995A Polyvinylarene substituted beta-diketones with anti-tumor effects |
| 05/05/2010 | CN101700394A Pharmaceutical composite for curing colon cancer and preparing method thereof |
| 05/05/2010 | CN101700393A Traditional Chinese medicine composition for treating breast cancer |
| 05/05/2010 | CN101700386A Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
| 05/05/2010 | CN101700382A Cancer pain elimination pill |
| 05/05/2010 | CN101700369A Combination of medicines for treating gastric and intestinal cancer |
| 05/05/2010 | CN101700356A Traditional Chinese medicine composition for treating breast cancer |
| 05/05/2010 | CN101700323A Pharmaceutical composition for preventing and treating liver cancer and prepration method thereof |
| 05/05/2010 | CN101700261A Anticarcinogen sweetsop ester as well as preparation method and application thereof |
| 05/05/2010 | CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 05/05/2010 | CN101700227A Matrine colon targeted adhesive pellet and preparation method thereof |
| 05/05/2010 | CN101700222A Oridonin solid dispersion preparation |